Buspirone does not cause a recognized withdrawal syndrome the way many other anxiety medications do. Unlike benzodiazepines, which can produce severe and well-documented withdrawal symptoms, buspirone has consistently shown little to no pharmacological dependence in clinical studies. If you’re experiencing symptoms after stopping buspirone, what you’re feeling is most likely the return of underlying anxiety rather than true drug withdrawal.
That said, the experience is real and uncomfortable regardless of the label. Here’s what the evidence shows about what happens when you stop buspirone and how long those symptoms typically last.
Why Buspirone Withdrawal Is Different
Buspirone works through a completely different brain pathway than benzodiazepines. Benzodiazepines boost the activity of a calming brain chemical called GABA, and when you stop taking them, your nervous system is left in an overexcited state. That’s what creates classic withdrawal: tremors, insomnia, seizure risk, and rebound anxiety that’s often worse than what you started with. In controlled studies, 33% to 100% of patients withdrawn from benzodiazepines after just 3 to 8 weeks of use experienced symptoms exceeding their original anxiety levels.
Buspirone, by contrast, works primarily on serotonin receptors. It doesn’t produce that same neurological dependence. A study published in The British Journal of Psychiatry directly compared buspirone and diazepam (a benzodiazepine) after 6 and 12 weeks of treatment. When both drugs were stopped, diazepam caused significantly greater withdrawal symptoms. The researchers concluded that 6 weeks of regular diazepam use creates a measurable risk of pharmacological dependence “that is not present with buspirone.” Another study found that when buspirone was stopped after 6 continuous months of use, there was no significant increase in symptom severity consistent with a withdrawal reaction.
What You’re Likely Feeling Instead
Buspirone has a short elimination half-life of about 2 to 3 hours, meaning the drug clears your system quickly. Once it’s gone, it’s no longer managing your anxiety. What most people experience after stopping isn’t withdrawal in the pharmacological sense. It’s the reemergence of the anxiety that buspirone was treating.
This can feel indistinguishable from withdrawal, especially if buspirone was working well for you. Common symptoms include:
- Increased anxiety or nervousness, sometimes feeling more intense than before you started the medication
- Irritability and restlessness
- Difficulty sleeping
- Dizziness or lightheadedness, particularly in the first few days
Because buspirone clears the body so quickly, these symptoms can begin within a day or two of your last dose. For most people, the acute discomfort of adjusting to life without the medication settles within 1 to 2 weeks. The underlying anxiety, however, may persist until it’s addressed through other treatment.
How Long the Adjustment Period Lasts
There’s no formal clinical timeline for “buspirone withdrawal” because the medical literature doesn’t recognize it as a distinct syndrome. But practically speaking, the timeline breaks into two phases.
In the first few days, you may notice physical symptoms like dizziness or mild nausea as the drug leaves your system. These tend to resolve within 3 to 7 days, consistent with the drug’s short half-life and the time it takes your body to fully adjust.
The longer phase involves anxiety symptoms returning, and this varies enormously from person to person. Some people feel a noticeable spike in anxiety for a week or two before settling at a manageable baseline. Others find their original anxiety returns in full and stays. The duration depends less on the drug and more on the nature of your anxiety disorder, how long you took buspirone, what dose you were on, and whether you have other coping strategies or treatments in place.
Whether Tapering Makes a Difference
Even though buspirone doesn’t cause classic withdrawal, many prescribers recommend a gradual taper rather than stopping abruptly. Reducing the dose over 1 to 2 weeks gives your body a gentler transition and can soften the rebound effect. A typical approach involves cutting the dose by small increments every few days.
Tapering is especially worth considering if you’ve been taking buspirone at higher doses (above 30 mg per day) or for several months or longer. It won’t prevent the return of anxiety entirely, but it can reduce the sharpness of the transition and give you time to notice how you feel at lower doses before stopping completely.
Factors That Affect Your Experience
Not everyone who stops buspirone notices much of anything. Several variables influence how noticeable the transition feels:
- How long you took it: Someone who used buspirone for a few weeks will generally have a smoother stop than someone who took it for years, simply because the brain has had less time to rely on it for anxiety regulation.
- Your dose: Higher doses provide more anxiety suppression, so stopping creates a larger gap between medicated and unmedicated states.
- Your baseline anxiety severity: If your underlying anxiety is significant, you’ll feel its return more acutely.
- Whether you stopped abruptly: Sudden discontinuation is more likely to cause a noticeable shift than a gradual taper.
- Other medications or therapies: If you’re also in therapy or using other treatments, the transition off buspirone tends to be less disruptive.
If Symptoms Last Longer Than Expected
If you’re still feeling significantly worse two to three weeks after stopping buspirone, that’s a strong signal that your anxiety disorder needs ongoing treatment rather than a sign of prolonged withdrawal. Unlike benzodiazepines or antidepressants, buspirone has not been associated with a protracted withdrawal syndrome lasting months.
Persistent symptoms after stopping likely mean the medication was doing meaningful work managing your anxiety, and a new treatment plan is worth discussing with your prescriber. Options might include restarting buspirone, trying a different medication, or intensifying therapy-based approaches.